快而精医药(QGEN)
icon
搜索文档
Qiagen (QGEN) Presents at the Morgan Stanley 20th Annual Global Healthcare Conference - Slideshow
2022-09-16 01:34
Making improvements in life possible Investor resource book Third quarter 2022 Sample to Insight Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. These s ...
QIAGEN(QGEN) - 2022 Q2 - Earnings Call Transcript
2022-07-29 12:43
Qiagen NV (NYSE:QGEN) Q2 2022 Earnings Conference Call July 28, 2022 9:30 AM ET Company Participants John Gilardi - VP, Corporate Communications & IR Thierry Bernard - CEO Roland Sacker - CFO Conference Call Participants Daniel Wendorff - ODDO BHF Patrick Donnelly - Citigroup Daniel Brennan - Cowen and Company Falko Friedrichs - Deutsche Bank Casey Woodring - JPMorgan Chase & Co. Matthew Sykes - Goldman Sachs Group Hugo Solvet - BNP Paribas Exane Operator Ladies and gentlemen, thank you for standing by. I a ...
QIAGEN(QGEN) - 2022 Q2 - Earnings Call Presentation
2022-07-29 11:29
Q2 2022 results Solid results with 10% CER sales growth in non-COVID portfolios Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent that any ...
QIAGEN(QGEN) - 2022 Q1 - Earnings Call Transcript
2022-04-29 04:15
QIAGEN N.V. (NYSE:QGEN) Q1 2022 Earnings Conference Call April 28, 2022 10:00 AM ET Company Participants John Gilardi - VP of Corporate Communications and IR Thierry Bernard - CEO Roland Sackers - CFO Conference Call Participants Patrick Donnelly - Citi Dan Arias - Stifel Derik De Bruin - Bank of America Matt Sykes - Goldman Sachs Dan Brennan - Cowen Casey Woodring - JPMorgan Jack Meehan - Nephron Research Operator Ladies and gentlemen, thank you for standing by. I am Elaine, your PGI call operator. Welcome ...
QIAGEN(QGEN) - 2021 Q4 - Earnings Call Presentation
2022-02-16 21:09
Q4 and full-year 2021 results Exceeded outlook with strong performance from non-COVID product groups Q4 and Full-year 2021 results Sample to Insight Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. ...
QIAGEN(QGEN) - 2021 Q4 - Earnings Call Transcript
2022-02-10 03:54
QIAGEN N.V. (NYSE:QGEN) Q4 2021 Earnings Conference Call February 9, 2022 9:00 AM ET Company Participants John Gilardi - Vice President of Corporate Communications & Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Tycho Peterson - JPMorgan Daniel Wendorff - ODDO BHF Jack Meehan - Nephron Research Dan Arias - Stifel Falko Friedrichs - Deutsche Bank Operator Please standby, we're about to begin. Ladies a ...
QIAGEN (QGEN) presents at 40th JPMorgan Annual Healthcare Conference (Slideshow)
2022-01-12 02:11
Sample to Insight | --- | --- | --- | --- | |-------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Emerging from change | | | | | with a strengthened profile | | | | | J.P. Morgan Healthcare Conference January 2022 | | | | | Thierry Bernard Chief Executive Officer | | | | Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements ...
QIAGEN(QGEN) - 2021 Q3 - Earnings Call Transcript
2021-11-05 03:55
QIAGEN N.V. (NYSE:QGEN) Q3 2021 Earnings Conference Call November 4, 2021 9:30 AM ET Company Participants John Gilardi - Vice President, Head-Corporate Communications and Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Falko Friedrichs - Deutsche Bank Tycho Peterson - JPMorgan Daniel Wendorff - Oddo BHF Derik de Bruin - Bank of America Scott Bardo - Berenberg Jack Meehan - Nephron Dan Brennan - Cowen Operator Ladies and gentl ...
QIAGEN (QGEN) Investor Presentation - Slideshow
2021-05-19 06:21
Sample to Insight Investor Presentation Q2 2021 Thierry Bernard Chief Executive Officer Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be, deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. To the extent t ...
QIAGEN(QGEN) - 2021 Q1 - Earnings Call Transcript
2021-05-05 13:28
QIAGEN N.V. (NYSE:QGEN) Q1 2021 Earnings Conference Call May 4, 2021 9:00 AM ET Company Participants John Gilardi – Vice President, Head-Corporate Communications and Investor Relations Thierry Bernard – Chief Executive Officer Roland Sackers – Chief Financial Officer Phoebe Loh – Senior Director-Investor Relations Conference Call Participants Patrick Donnelly – Citi Daniel Wendorff – Commerzbank Scott Bardo – Berenberg Doug Schenkel – Cowen John Sourbeer – UBS Falko Friedrichs – Deutsche Bank Brian Weinstei ...